Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 4744

1.

Characteristics and prognosis of IgG4-related periaortitis/periarteritis: A systematic literature review.

Akiyama M, Kaneko Y, Takeuchi T.

Autoimmun Rev. 2019 Jul 16:102354. doi: 10.1016/j.autrev.2019.102354. [Epub ahead of print] Review.

PMID:
31323364
2.

Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease.

Matsuda S, Kotani T, Ishida T, Fukui K, Fujiki Y, Suzuka T, Nagai K, Hata K, Shoda T, Isoda K, Ito Y, Makino S, Takeuchi T, Arawaka S.

Rheumatology (Oxford). 2019 Jul 18. pii: kez301. doi: 10.1093/rheumatology/kez301. [Epub ahead of print]

PMID:
31321420
3.

Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.

Fujita K, Matsubara T, Miyamoto R, Sumikura H, Takeuchi T, Maruyama Saladini K, Kawarai T, Nodera H, Udaka F, Kume K, Morino H, Kawakami H, Hasegawa M, Kaji R, Murayama S, Izumi Y.

BMC Neurol. 2019 Jul 18;19(1):168. doi: 10.1186/s12883-019-1402-7.

4.

Design, Synthesis, and Biological Evaluation of EdAP, a 4'-Ethynyl-2'-Deoxyadenosine 5'-Monophosphate Analog, as a Potent Influenza a Inhibitor.

Takeuchi T, Sriwilaijaroen N, Sakuraba A, Hayashi E, Kamisuki S, Suzuki Y, Ohrui H, Sugawara F.

Molecules. 2019 Jul 17;24(14). pii: E2603. doi: 10.3390/molecules24142603.

5.

Subtypes in eosinophilic granulomatosis with polyangiitis classified according to rheumatoid factor.

Inamo J, Kaneko Y, Ota Y, Takeuchi T.

Clin Rheumatol. 2019 Jul 17. doi: 10.1007/s10067-019-04680-5. [Epub ahead of print]

PMID:
31317422
6.

Melatonin is a potential drug for the prevention of bone loss during space flight.

Ikegame M, Hattori A, Tabata MJ, Kitamura KI, Tabuchi Y, Furusawa Y, Maruyama Y, Yamamoto T, Sekiguchi T, Matsuoka R, Hanmoto T, Ikari T, Endo M, Omori K, Nakano M, Yashima S, Ejiri S, Taya T, Nakashima H, Shimizu N, Nakamura M, Kondo T, Hayakawa K, Takasaki I, Kaminishi A, Akatsuka R, Sasayama Y, Nishiuchi T, Nara M, Iseki H, Chowdhury VS, Wada S, Ijiri K, Takeuchi T, Suzuki T, Ando H, Matsuda K, Somei M, Mishima H, Mikuni-Takagaki Y, Funahashi H, Takahashi A, Watanabe Y, Maeda M, Uchida H, Hayashi A, Kambegawa A, Seki A, Yano S, Shimazu T, Suzuki H, Hirayama J, Suzuki N.

J Pineal Res. 2019 Jul 9:e12594. doi: 10.1111/jpi.12594. [Epub ahead of print]

PMID:
31286565
7.

Uncertainty about flying conspecifics causes territorial contests of the Old World swallowtail, Papilio machaon.

Takeuchi T, Yabuta S, Takasaki H.

Front Zool. 2019 Jun 24;16:22. doi: 10.1186/s12983-019-0324-y. eCollection 2019.

8.

[Effectiveness of Ramucirumab Therapy for Advanced Gastric Cancer after Stent Placement for Esophagogastric Junction Carcinoma Obstruction-A Case Report].

Takeuchi T, Yuasa Y, Okitsu H, Maki H, Tsuneki T, Matsuo Y, Edagawa H, Mori O, Miyamoto N, Eto S, Fujiwara S, Tomibayashi A, Ishikura H.

Gan To Kagaku Ryoho. 2019 Jun;46(6):1057-1059. Japanese.

PMID:
31273175
9.

Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: results of the HAWK postmarketing surveillance study in Japan.

Tanaka Y, Mimori T, Yamanaka H, Sunaga N, Morita K, Kimura J, Takeuchi T.

Mod Rheumatol. 2019 Jul 3:1-24. doi: 10.1080/14397595.2019.1639931. [Epub ahead of print]

PMID:
31267801
10.

An Approach for the Identification of Proteins Modified with ISG15.

Takeuchi T, Koinuma S, Yokosawa H, Arata Y.

Methods Mol Biol. 2019;1934:235-246. doi: 10.1007/978-1-4939-9055-9_15.

PMID:
31256383
11.

Endoscopic Evaluation of Neoadjuvant Chemotherapeutic Efficacy in Gastric Cancer before Gastrectomy Might be as Useful as Histological Assessment after Gastrectomy.

Sugawara N, Ota K, Terazawa T, Tanaka R, Akutagawa H, Yamaguchi T, Imai Y, Harada S, Kojima Y, Tashiro K, Kii T, Lee SW, Kawai M, Egashira Y, Goto M, Uchiyama K, Hirose Y, Takeuchi T, Higuchi K.

Digestion. 2019 Jun 28:1-7. doi: 10.1159/000500907. [Epub ahead of print]

PMID:
31256160
12.

An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway.

Hano K, Hatano K, Saigo C, Kito Y, Shibata T, Takeuchi T.

Mol Biol Rep. 2019 Jun 28. doi: 10.1007/s11033-019-04947-9. [Epub ahead of print]

PMID:
31254244
13.

Advanced microinjection protocol for gene manipulation using the model newt Pleurodeles waltl.

Hayashi T, Nakajima M, Kyakuno M, Doi K, Manabe I, Azuma S, Takeuchi T.

Int J Dev Biol. 2019;63(6-7):281-286. doi: 10.1387/ijdb.180297th.

PMID:
31250911
14.

Body mass index associates with disease relapse in patients with giant cell arteritis.

Matsumoto K, Kaneko Y, Takeuchi T.

Int J Rheum Dis. 2019 Jun 27. doi: 10.1111/1756-185X.13642. [Epub ahead of print]

PMID:
31245915
15.

E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.

Sakai R, Suzuki M, Ueyama M, Takeuchi T, Minakawa EN, Hayakawa H, Baba K, Mochizuki H, Nagai Y.

PLoS One. 2019 Jun 26;14(6):e0218261. doi: 10.1371/journal.pone.0218261. eCollection 2019.

16.

Efficacy and safety of long-term baricitinib with and without methotrexate for the treatment of rheumatoid arthritis: experience with baricitinib monotherapy continuation or after switching from methotrexate monotherapy or baricitinib plus methotrexate.

Fleischmann R, Takeuchi T, Schiff M, Schlichting D, Xie L, Issa M, Stoykov I, Lisse J, Martinez-Osuna P, Rooney T, Zerbini CAF.

Arthritis Care Res (Hoboken). 2019 Jun 24. doi: 10.1002/acr.24007. [Epub ahead of print]

PMID:
31233281
17.

Loosening of Lipid Packing by Cell Surface Recruitment of Amphiphilic Peptides by Coiled-coil Tethering.

Sakai T, Kawano K, Iino M, Takeuchi T, Imanishi M, Futaki S.

Chembiochem. 2019 Jun 21. doi: 10.1002/cbic.201900347. [Epub ahead of print]

PMID:
31225928
18.

Association of radiographic findings in hand X-ray with clinical features and autoantibodies in patients with systemic sclerosis.

Sakata K, Kaneko Y, Yasuoka H, Takeuchi T.

Clin Rheumatol. 2019 Jun 18. doi: 10.1007/s10067-019-04639-6. [Epub ahead of print]

PMID:
31214867
19.

High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations.

Nakagawa N, Sawada J, Sakamoto N, Takeuchi T, Takahashi F, Maruyama JI, Momosaki K, Nakamura K, Endo F, Hasebe N.

J Hum Genet. 2019 Jun 19. doi: 10.1038/s10038-019-0633-1. [Epub ahead of print]

PMID:
31213654
20.

Achieving Pain Control in Rheumatoid Arthritis with Baricitinib or Adalimumab Plus Methotrexate: Results from the RA-BEAM Trial.

Taylor PC, Lee YC, Fleischmann R, Takeuchi T, Perkins EL, Fautrel B, Zhu B, Quebe AK, Gaich CL, Zhang X, Dickson CL, Schlichting DE, Patel H, Durand F, Emery P.

J Clin Med. 2019 Jun 12;8(6). pii: E831. doi: 10.3390/jcm8060831.

21.

Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.

Hozumi K, Fukuoka H, Odake Y, Takeuchi T, Uehara T, Sato T, Inoshita N, Yoshida K, Matsumoto R, Bando H, Hirota Y, Iguchi G, Taniguchi M, Otsuki N, Nishigori C, Kosaki K, Hasegawa T, Ogawa W, Takahashi Y.

Endocr J. 2019 Jun 12. doi: 10.1507/endocrj.EJ19-0035. [Epub ahead of print]

22.

CD151 confers metastatic potential to clear cell sarcoma of the soft tissue in animal model.

Kawashima K, Saigo C, Kito Y, Hanamatsu Y, Egawa Y, Takeuchi T.

Oncol Lett. 2019 Jun;17(6):4811-4818. doi: 10.3892/ol.2019.10164. Epub 2019 Mar 19.

23.

[Current status and problems of gastrointestinal bleeding induced by antithrombotic drugs including DOAC].

Harada S, Takeuchi T, Higuchi K.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(6):488-498. doi: 10.11405/nisshoshi.116.488. Japanese. No abstract available.

PMID:
31178578
24.

Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.

Takeshita M, Suzuki K, Kondo Y, Morita R, Okuzono Y, Koga K, Kassai Y, Gamo K, Takiguchi M, Kurisu R, Mototani H, Ebisuno Y, Yoshimura A, Takeuchi T.

Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2018-214885. doi: 10.1136/annrheumdis-2018-214885. [Epub ahead of print]

25.

Molecular mechanism and potential target indication of TAK-931, a novel CDC7-selective inhibitor.

Iwai K, Nambu T, Dairiki R, Ohori M, Yu J, Burke K, Gotou M, Yamamoto Y, Ebara S, Shibata S, Hibino R, Nishizawa S, Miyazaki T, Homma M, Oguro Y, Imada T, Cho N, Uchiyama N, Kogame A, Takeuchi T, Kurasawa O, Yamanaka K, Niu H, Ohashi A.

Sci Adv. 2019 May 22;5(5):eaav3660. doi: 10.1126/sciadv.aav3660. eCollection 2019 May.

26.
27.

Smoking and pancreatic cancer incidence: a pooled analysis of ten population-based cohort studies in Japan.

Koyanagi YN, Ito H, Matsuo K, Sugawara Y, Hidaka A, Sawada N, Wada K, Nagata C, Tamakoshi A, Lin Y, Takeuchi T, Kitamura Y, Utada M, Sadakane A, Mizoue T, Naito M, Tanaka K, Shimazu T, Tsugane S, Inoue M.

Cancer Epidemiol Biomarkers Prev. 2019 May 21. pii: cebp.1327.2018. doi: 10.1158/1055-9965.EPI-18-1327. [Epub ahead of print]

PMID:
31113869
28.

The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method.

Yajima N, Tsujimoto Y, Fukuma S, Sada KE, Shimizu S, Niihata K, Takahashi R, Asano Y, Azuma T, Kameda H, Kuwana M, Kohsaka H, Sugiura-Ogasawara M, Suzuki K, Takeuchi T, Tanaka Y, Tamura N, Matsui T, Mimori T, Fukuhara S, Atsumi T.

Mod Rheumatol. 2019 Jun 26:1-7. doi: 10.1080/14397595.2019.1621419. [Epub ahead of print]

PMID:
31111758
29.

Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.

Kato M, Kaneko Y, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Nagasawa H, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Yokota I, Atsumi T, Takeuchi T.

Mod Rheumatol. 2019 Jun 7:1-8. doi: 10.1080/14397595.2019.1621026. [Epub ahead of print]

PMID:
31106666
30.

[Improvement of Fat Suppressing Effect for Finger and Neck MRI by Using Small Glass Beads].

Shiina R, Ogura A, Takeuchi T, Nakano H.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(5):446-453. doi: 10.6009/jjrt.2019_JSRT_75.5.446. Japanese.

31.

Role of peptide transporter 2 and MAPK signaling pathways in the innate immune response induced by bacterial peptides in alveolar epithelial cells.

Takano M, Takeuchi T, Kuriyama S, Yumoto R.

Life Sci. 2019 Jul 15;229:173-179. doi: 10.1016/j.lfs.2019.05.042. Epub 2019 May 16.

PMID:
31103606
32.

Adaptation and visual discomfort from flicker.

Yoshimoto S, Jiang F, Takeuchi T, Wilkins AJ, Webster MA.

Vision Res. 2019 Jul;160:99-107. doi: 10.1016/j.visres.2019.04.010. Epub 2019 May 25.

PMID:
31091424
33.

Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H.

PLoS One. 2019 May 8;14(5):e0216624. doi: 10.1371/journal.pone.0216624. eCollection 2019.

34.

Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H.

Arthritis Res Ther. 2019 May 6;21(1):114. doi: 10.1186/s13075-019-1897-8.

35.

Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.

Takeuchi T, Hongo H, Kimura T, Kojima Y, Harada S, Ota K, Takeuchi N, Noguchi T, Inoue T, Murano M, Higuchi K.

J Gastroenterol. 2019 Apr 29. doi: 10.1007/s00535-019-01588-4. [Epub ahead of print]

PMID:
31037449
36.

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial.

Takeuchi T, Tanaka Y, Soen S, Yamanaka H, Yoneda T, Tanaka S, Nitta T, Okubo N, Genant HK, van der Heijde D.

Ann Rheum Dis. 2019 Jul;78(7):899-907. doi: 10.1136/annrheumdis-2018-214827. Epub 2019 Apr 29.

37.

Potential of biocompatible polymeric ultra-thin films, nanosheets, as topical and transdermal drug delivery devices.

Hatanaka T, Saito T, Fukushima T, Todo H, Sugibayashi K, Umehara S, Takeuchi T, Okamura Y.

Int J Pharm. 2019 Jun 30;565:41-49. doi: 10.1016/j.ijpharm.2019.04.059. Epub 2019 May 6.

PMID:
31022503
38.

Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.

Minashi K, Nihei K, Mizusawa J, Takizawa K, Yano T, Ezoe Y, Tsuchida T, Ono H, Iizuka T, Hanaoka N, Oda I, Morita Y, Tajika M, Fujiwara J, Yamamoto Y, Katada C, Hori S, Doyama H, Oyama T, Nebiki H, Amagai K, Kubota Y, Nishimura K, Kobayashi N, Suzuki T, Hirasawa K, Takeuchi T, Fukuda H, Muto M.

Gastroenterology. 2019 Apr 20. pii: S0016-5085(19)36710-1. doi: 10.1053/j.gastro.2019.04.017. [Epub ahead of print]

39.

A comprehensive reference transcriptome resource for the Iberian ribbed newt Pleurodeles waltl, an emerging model for developmental and regeneration biology.

Matsunami M, Suzuki M, Haramoto Y, Fukui A, Inoue T, Yamaguchi K, Uchiyama I, Mori K, Tashiro K, Ito Y, Takeuchi T, Suzuki KT, Agata K, Shigenobu S, Hayashi T.

DNA Res. 2019 Jun 1;26(3):217-229. doi: 10.1093/dnares/dsz003.

41.

Site-specific post-imprinting modification of molecularly imprinted polymer nanocavities with a modifiable functional monomer for prostate cancer biomarker recognition.

Matsumoto H, Sunayama H, Kitayama Y, Takano E, Takeuchi T.

Sci Technol Adv Mater. 2019 Apr 1;20(1):305-312. doi: 10.1080/14686996.2019.1583495. eCollection 2019.

42.

Experimental Evidence of Liver Injury by BSEP-Inhibiting Drugs With a Bile Salt Supplementation in Rats.

Yang F, Takeuchi T, Tsuneyama K, Yokoi T, Oda S.

Toxicol Sci. 2019 Jul 1;170(1):95-108. doi: 10.1093/toxsci/kfz088.

PMID:
30985903
43.

Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis.

Tani H, Nagai K, Hosokawa T, Hata K, Kotani T, Ishida S, Takeuchi T, Arawaka S.

J Neurol. 2019 Jul;266(7):1708-1715. doi: 10.1007/s00415-019-09318-9. Epub 2019 Apr 13.

PMID:
30982149
44.

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.

Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H.

Arthritis Res Ther. 2019 Apr 11;21(1):91. doi: 10.1186/s13075-019-1880-4. Erratum in: Arthritis Res Ther. 2019 May 6;21(1):114.

45.

A Randomized Placebo-controlled Trial of an Oral Preparation of High Molecular Weight Fucoidan in Patients with Type 2 Diabetes with Evaluation of Taste Sensitivity.

Sakai C, Abe S, Kouzuki M, Shimohiro H, Ota Y, Sakinada H, Takeuchi T, Okura T, Kasagi T, Hanaki K.

Yonago Acta Med. 2019 Mar 28;62(1):14-23. eCollection 2019 Mar.

46.
47.

Occupational class differences in pancreatic cancer survival: A population-based cancer registry-based study in Japan.

Zaitsu M, Kim Y, Lee HE, Takeuchi T, Kobayashi Y, Kawachi I.

Cancer Med. 2019 Jun;8(6):3261-3268. doi: 10.1002/cam4.2138. Epub 2019 Apr 5.

48.

Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.

Tokuhira M, Saito S, Suzuki K, Higashi M, Momose S, Shimizu T, Mori T, Kimura Y, Amano K, Okamoto S, Takeuchi T, Tamaru JI, Kizaki M.

Leuk Lymphoma. 2019 Apr 5:1-8. doi: 10.1080/10428194.2019.1585841. [Epub ahead of print]

PMID:
30947579
49.

Effect of spatial attention on spatiotopic visual motion perception.

Yoshimoto S, Takeuchi T.

J Vis. 2019 Apr 1;19(4):4. doi: 10.1167/19.4.4.

PMID:
30943532
50.

CREG1 stimulates brown adipocyte formation and ameliorates diet-induced obesity in mice.

Hashimoto M, Kusudo T, Takeuchi T, Kataoka N, Mukai T, Yamashita H.

FASEB J. 2019 Jul;33(7):8069-8082. doi: 10.1096/fj.201802147RR. Epub 2019 Mar 27.

PMID:
30917000

Supplemental Content

Loading ...
Support Center